More than 90 people have presented to emergency departments in Illinois and four other states since March 10 with serious unexplained bleeding, including two patients who died, the Centers for Disease Control and Prevention said yesterday in an alert to clinicians. All but five of the cases were in Illinois, including the two deaths, and the rest were in Indiana, Maryland, Missouri and Wisconsin. Laboratory investigation confirmed exposure to brodifacoum, a vitamin K antagonist anticoagulant, in at least 18 of the patients. All 63 patients interviewed by Illinois public health epidemiologists reported using synthetic cannabinoids, and at least three synthetic cannabinoid product samples related to the outbreak have tested positive for brodifacoum, CDC said. Health care providers should screen patients presenting with unexplained bleeding and a possible history of synthetic cannabinoid for vitamin K-dependent antagonist coagulopathy, and report suspected cases associated with synthetic cannabinoids to their local health department, the agency said.

Related News Articles

Seventeen health insurance, employer and consumer organizations today proposed recommendations for federal action to protect patients from surprise medical…
Historic flooding in parts of the Midwest caused a number of Nebraska hospitals to be inaccessible by ground transportation, the Nebraska Hospital Association…
Legislative proposals for a Medicare public option could negatively affect patient access to care and significantly reduce payments to hospitals, AHA Executive…
Adjusting for social risk factors such as poverty, disability and housing instability in the Hospital Readmissions Reduction Program could level the playing…
Insights and Analysis
Pictured, from left to right: Manik Bhat, CEO of Healthify, Inc.; Carmen Llanes Pulido, executive director at Go Austin/Vamos Austin; Dwayne Pr
Chairperson's File
I was pleased to take part in a robust discussion about new leadership competencies last week in conjunction with the South by Southwest Festival.